The right to search for truth implies also a duty; one must not conceal any part of what one has recognized to be true.
--Albert Einstein (inscribed on the base of the Albert Einstein memorial at the National Academy of Sciences)
The success of the scientific enterprise requires first of all that scientists must embody honesty and integrity in every phase of their work. Without the uncompromising integrity of everyone involved in research, the entire edifice of science will eventually collapse, because each new layer of knowledge is built on the accuracy and truth of the research that preceded it.
A great deal has been written in recent years on research integrity, fueled by such highly publicized cases as those involving Thereza Imanishi Kari and David Baltimore in Boston 1 ,
Robert Gallo at the NIH 2 , and Francis Collins at the Human Genome Project, 3 each accused of transgressions against the ethical and legal norms that guide research. Integrity in science means that the investigators accept responsibility for all aspects of a study, from experimental design through all stages of its execution, including publication. It implies that each of these steps will be carried out with competence and honesty.
Integrity in research cannot be assured by law; it must come from the character of those who carry out research. Nevertheless, medical journals have an important role to play in reminding those who do research of their obligations to science. For example, conflicts of interest arising from financial or other kinds of ties to companies whose products are being studied may be a source of bias in reporting research results. Journals have taken several different approaches to dealing with these kinds of conflicts. Taking a firm position, the New England Journal of Medicine in 1990 announced a policy in which they would refuse to publish any article or editorial written by an employee of a company (or its competition) whose product is important to the topic under discussion. 4 Many protested that this policy was overly zealous, akin to throwing out the baby with the bath water. For example, under a policy of this kind, it has been pointed out, Thomas Edison could not have published an article on the future of electricity. . 10 In their editorial, the group of editors concluded that, because a manuscript is the intellectual property of the research scientists rather than the sponsors of the study, "we will not review or publish articles based on studies that are conducted under conditions that allow the sponsor to have sole control of the data or to withhold publication."
The editors of the Annals and the Journal have expressed support for the general thrust of the multi-authored editorial. They also support a specific policy to consider rejecting a manuscript describing a study in which an entity other than the investigator either had sole control of the data or had veto power over publication. Both the Annals and the Journal have added new language to their respective "Information For Authors" pages that reflects this policy change.
The added language states: "Each author must indicate whether or not he or she has had full 'Freedom of Investigation' before, during and after this study. 'Freedom of Investigation' is defined as freedom from outside interests controlling the design of the study, acquisition of data, collection, analysis, and interpretation of data, or having veto power over full disclosure of the results." If the investigators did not have full freedom of investigation, a letter of explanation will be required, and publication may be denied.
Collaboration between industry and research scientists has been abundantly fruitful, and university administrations have put in place systems that accommodate industry sponsored research. These have made possible great advances in the care of thoracic surgical patients. Yet, there have been occasions when these usually nurturing hands have challenged the integrity of science. The journal policy we describe is intended to have two effects. One is to give investigators powerful support from our specialty's most prestigious and largest circulation journals in negotiating ethically acceptable contracts with industrial sponsors and in dealing with undue delays imposed by others, such as intellectual property officers of universities. The second is to assure that readers of our journals have enough information to make informed judgments about potential biases in research results and their interpretation, with the understanding that the authors had control of the data and its analysis and of the decision to publish. The accuracy of the information provided to the editors rests upon the long tradition of expecting that the information requested of authors will be provided fully and honestly. Journals must be able to rely on the integrity and honesty of investigators in providing accurate information to their readers, for these character traits are the life blood of the entire corpus of cardiothoracic research and the clinical practices that depend upon it.
